European Biotech Industry Laments Retreat From E.U.-Wide Patent System

Law360, New York (July 20, 2005, 12:00 AM EDT) -- Europe’s biotech industry is bitterly disappointed with the European Commission’s decision to throw in the towel in its efforts to create a European-wide system for biotech patenting.

EuropaBio, the European association for bioindustries, said it was “disappointed” that the European Union’s executive body had not taken a “firmer stand” on harmonizing rules for patenting human DNA sequences across EU member states in its second report on the EU Biotechnology Patents Directive.

“The main objective for introducing the Directive in 1988 and in 1995 was to harmonize...
To view the full article, register now.